Identification of key genes and metabolites in thyroid eye disease through integrated transcriptomic and metabolomic analysis
Introduction Thyroid eye disease (TED) markedly compromises ocular function and quality of life, imposing significant healthcare and economic burdens. Present therapeutic strategies, which mainly include glucocorticoids, teprotumumab, immunosuppressive drugs, and surgical treatments, exhibit limited effectiveness and a...